Korean J Pain.  2017 Apr;30(2):85-85. 10.3344/kjp.2017.30.2.85.

Medications for osteoporotic pain

• Shin SW

• KMID: 2376042
• DOI: http://doi.org/10.3344/kjp.2017.30.2.85

Abstract

No abstract available.

MeSH Terms

Fractures
Compression Pain

Reference

1. Mattia C, Coluzzi F, Celidonio L, Vellucci R. Bone pain mechanism in osteoporosis: a narrative review. Clin Cases Miner Bone Metab. 2016; 13:97–100. PMID: 27920803.

2. Lee YJ, Park CH, Lee YK, Ha YC, Koo KH. Which bisphosphonate? It's the compliance!: decision analysis. J Bone Metab. 2016; 23:79–83. PMID: 27294079.

3. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014; 25:2359–2381. PMID: 25182228.

4. Kim SY, Ok HG, Birkenmaier C, Kim KH. Can denosumab be a substitute, competitor, or compliment to bisphosphonates? Korean J Pain. 2017; 30:86–92.

5. Tetsunaga T, Tetsunaga T, Nishida K, Tanaka M, Sugimoto Y, Takigawa T, et al. Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures. J Orthop Sci. 2017; 22:230–236. PMID: 28087216.